Home › Funds › Velan Capital Investment Management LP › MPLT
Velan Capital Investment Management LP position in MPLT
MAPLIGHT THERAPEUTICS INC · Health Care
Velan Capital Investment Management LP reported holding 624,703 shares of MPLT (MAPLIGHT THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$6.4M, representing 6.08% of its reported portfolio and ranking #6 among its reported holdings. Velan Capital Investment Management LP has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Velan Capital Investment Management LP's MPLT position evolved
Velan Capital Investment Management LP first disclosed a stake in MPLT in Q4 2025 at 522,305 shares (US$9.2M). The position peaked in Q2 2026 at 492,893 shares, worth US$17.7M. Across 4 filings, Velan Capital Investment Management LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 624,703 shares valued at US$6.4M — an increase of 131,810 shares quarter over quarter.. Notable position changes include a 27% increase in Q3 2026 (shares fell 29% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 522.30K | $9.17M | New |
| Q1 2026 | 492.89K | $10.02M | Reduce |
| Q2 2026 | 492.89K | $17.67M | Hold |
| Q3 2026 | 624.70K | $6.37M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MPLT and 13F data
MPLT (MAPLIGHT THERAPEUTICS INC) is a Health Care company. 86 other funds we track also report a position in MPLT — the largest reported positions include Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$45.1M), 5AM Venture Management, LLC (US$34.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MPLT
- Novo Holdings A/S 3.69M sh · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 4.43M sh · $45.12M · Q3 2026
- 5AM Venture Management, LLC 950.01K sh · $34.05M · Q2 2026
- Nan Fung Group Holdings Ltd 2.30M sh · $23.44M · Q3 2026
- Sanofi 912.04K sh · $9.29M · Q3 2026
- Pivotal bioVenture Partners Investment Advisor LLC 611.45K sh · $6.23M · Q3 2026
- DAFNA Capital Management LLC 171.01K sh · $6.13M · Q2 2026
- Blue Owl Capital Holdings LP 556.37K sh · $5.67M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 118.30K sh · $1.21M · Q3 2026
More on Velan Capital Investment Management LP
FAQ
How long has Velan Capital Investment Management LP held MPLT?
Velan Capital Investment Management LP has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Velan Capital Investment Management LP's current position in MPLT?
As of Q3 2026, Velan Capital Investment Management LP holds 624.70K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $6.37M, representing 6.08% of its reported portfolio and ranking #6.
Has Velan Capital Investment Management LP been buying or selling MPLT?
In the latest 13F filing (Q3 2026), Velan Capital Investment Management LP increased its position in MPLT. The position peaked in Q2 2026 at 492.89K shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., 5AM Venture Management, LLC, among 86 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.